Should the FDA Do More to Identify Unsafe Drugs? A new report says the drug safety system is flawed and needs fixing. Guests discuss the safety of prescription drugs and what changes the Food and Drug Administration should make to ensure the safety of medicine.
NPR logo

Should the FDA Do More to Identify Unsafe Drugs?

  • Download
  • <iframe src="https://www.npr.org/player/embed/6167291/6167292" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript
Should the FDA Do More to Identify Unsafe Drugs?

Should the FDA Do More to Identify Unsafe Drugs?

Should the FDA Do More to Identify Unsafe Drugs?

  • Download
  • <iframe src="https://www.npr.org/player/embed/6167291/6167292" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

A new report says the drug safety system is flawed and needs fixing. Guests discuss the safety of prescription drugs and what changes the Food and Drug Administration should make to ensure the safety of medicine.

Guests:

Sheila Burke, deputy secretary and chief operating officer for the Smithsonian Institution; chair, Committee on the Assessment of the U.S. Drug Safety System at the Institute of Medicine

Scott Lassman, senior assistant general counsel, Pharmaceutical Research and Manufacturers of America (PhRMA)